Anti-tumor necrosis factor-alpha monoclonal antibody treatment in a case with persistent juvenile ankylosing spondylitis and inflammatory bowel disease [Jüvenil ankilozan spondilit ve enflamatuvar bagirsak hastaligi olan bir hastada anti-tümör nekrozis faktör-alfa monoklonal antikor tedavisi]
| dc.contributor.author | Öztürk C. | |
| dc.contributor.author | Genel F. | |
| dc.contributor.author | Aksu G. | |
| dc.contributor.author | Bakiler A.R. | |
| dc.contributor.author | Kütükçüler N. | |
| dc.date.accessioned | 2019-10-27T00:23:14Z | |
| dc.date.available | 2019-10-27T00:23:14Z | |
| dc.date.issued | 2003 | |
| dc.department | Ege Üniversitesi | en_US |
| dc.description.abstract | Juvenile ankylosing spondylitis and inflammatory bowel disease rarely develop simultaneously, and the treatment of the disease with disease-modifying antirheumatic drugs might be difficult. In this report we present an eight-year old boy with juvenile ankylosing spondylitis and inflammatory bowel disease resistant to combined therapy of antirheumatismal drugs because of its rarity in childhood. Anti-tumor necrosis factor-? monoclonal antibody administration, a new biological treatment, is discussed in view of the literature. | en_US |
| dc.identifier.endpage | 206 | en_US |
| dc.identifier.issn | 0010-0161 | |
| dc.identifier.issn | 0010-0161 | en_US |
| dc.identifier.issue | 3 | en_US |
| dc.identifier.scopusquality | Q4 | en_US |
| dc.identifier.startpage | 203 | en_US |
| dc.identifier.uri | https://hdl.handle.net/11454/22767 | |
| dc.identifier.volume | 46 | en_US |
| dc.indekslendigikaynak | Scopus | en_US |
| dc.language.iso | tr | en_US |
| dc.relation.ispartof | Cocuk Sagligi ve Hastaliklari Dergisi | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Anti-tumor necrosis factor-? monoclonal antibody | en_US |
| dc.subject | Inflammatory bowel disease | en_US |
| dc.subject | Juvenile ankylosing spondylitis | en_US |
| dc.title | Anti-tumor necrosis factor-alpha monoclonal antibody treatment in a case with persistent juvenile ankylosing spondylitis and inflammatory bowel disease [Jüvenil ankilozan spondilit ve enflamatuvar bagirsak hastaligi olan bir hastada anti-tümör nekrozis faktör-alfa monoklonal antikor tedavisi] | en_US |
| dc.type | Article | en_US |
